Details for New Drug Application (NDA): 210666
✉ Email this page to a colleague
The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for 210666
Tradename: | PHENYLEPHRINE HYDROCHLORIDE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | phenylephrine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 210666
Mechanism of Action | Adrenergic alpha1-Agonists |
Medical Subject Heading (MeSH) Categories for 210666
Suppliers and Packaging for NDA: 210666
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210666 | ANDA | Fresenius Kabi USA, LLC | 63323-751 | 63323-751-13 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-751-13) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-751-03) |
PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210666 | ANDA | Fresenius Kabi USA, LLC | 63323-751 | 63323-751-05 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-751-05) / 5 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/5ML (10MG/ML) | ||||
Approval Date: | Jan 30, 2019 | TE: | AP1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/10ML (10MG/ML) | ||||
Approval Date: | Jan 30, 2019 | TE: | AP1 | RLD: | No |
Complete Access Available with Subscription